Tyroservaltide
| Code | Size | Price |
|---|
| TAR-T29027-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Tyroservaltide is a HDAC inhibitor.
CAS:
154039-16-4
Formula:
C17H25N3O6
Molecular Weight:
367.402
Purity:
0.98
SMILES:
CC(C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O
References
1. Che XC, Lu R, Hu JX, Zheng MN, Zhang MF, Wang S, Yu CY, Yang XL, Xing DH, Yao Z. [Inhibitory effect of tripeptide compound tyroservaltide on invasion and metastasis of mouse melanoma cell line B16-F10]. Ai Zheng. 2006 Mar;25(3):275-80. Chinese. PubMed PMID: 16536978.
2. Jia J, Lu R, Qiu S, Li H, Che X, Zhao P, Jin M, Yang H, Lin G, Yao Z. Preliminary investigation of the inhibitory effects of the tyroservaltide (YSV) tripeptide on human hepatocarcinoma BEL-7402. Cancer Biol Ther. 2005 Sep;4(9):993-7. PubMed PMID: 16082190.